GSK’s Momelotinib Granted FDA Approval for Myelofibrosis Anemia Treatment

In a significant development for the healthcare industry, London-based pharmaceutical giant GlaxoSmithKline Plc (GSK.L) has received approval from the U.S. Food and Drug Administration...

Critical Health Access at Risk as GSK Ceases Operations

In a move that has sparked concerns over access to essential healthcare products, GSK UK Group has announced its strategic intent to halt the...

GSK’s Dostarlimab for Womb Cancer to be Reviewed by EU Drug Watchdog

British pharmaceutical company GSK has announced that the European Medicines Agency (EMA) will be reviewing its new treatment for a common type of womb...


Free Access To Our Email Exclusive ContentThe Greatest Wealth is Health

Join thousands of subscribers benefiting from our exclusive premium content on health and wellness, food and recipes, beauty, home and garden, and everything in between.